Abstract
Chemotherapy and targeted therapy have greatly enhanced the prognosis of patients with oncology. Nevertheless, such antineoplastic therapies can also cause unwanted cardiovascular effects, which can be followed by acute or late-onset cardiac dysfunction. These frequent cardiovascular complications, usually called cardiotoxicity, not only can necessitate the adjustment, interruption, or withdrawal of life-saving antineoplastic treatments, with the risk of diminishing their effectiveness, but also can significantly influence the quality of life and survival, irrespective of the oncological prognosis. The development of cardiotoxicity can be dependent on the class, dose, route, and duration of administration of anticancer agents, as well as on individual risk factors. Notably, the cardiotoxic side effects can be reversible, if cardiac function is resumed upon termination of the treatment, or irreversible, in that it is associated with injury and loss of cardiac muscle cells. Subclinical myocardial dysfunction caused by anticancer treatments may also later progress into symptomatic congestive heart failure. Thus, there is a pressing requirement for cardioprotective therapy to decrease the clinical and subclinical cardiotoxicity onset and progression and the acute or chronic manifestation of cardiac injuries. Here in, we review the information about cellular and molecular mechanisms underlying the development of cardiotoxicity from standard classes of chemotherapeutic and targeted therapy agents. In addition, we outline and discuss existing and future approaches to managing the cardiotoxic side effects and cardioprotective preventive measures that would be beneficial to flank anticancer therapies.
Keywords
Anticancer, Chemotherapy Cardiotoxicity, Dose
Citations
IRE Journals:
Aditya Ganesh Bhagwat , Khushal Chaudhari , Prajkta Bhoj
"The Cardiotoxicity Caused by Anticancer Drugs" Iconic Research And Engineering Journals Volume 8 Issue 9 2025 Page 1330-1342
IEEE:
Aditya Ganesh Bhagwat , Khushal Chaudhari , Prajkta Bhoj
"The Cardiotoxicity Caused by Anticancer Drugs" Iconic Research And Engineering Journals, 8(9)
About IRE Journals
IRE Journals is an open access online journals established with an aim to publish high quality of research work in various diciplines. We have more than 6 years in publications. Over 2500+ papers already published.
Important Links
For Authors
Volume 7:
Issue 1, Issue 2, Issue 3, Issue 4, Issue 5, Issue 6, Issue 7, Issue 8, Issue 9, Issue 10, Issue 11, Issue 12Volume 6:
Issue 1, Issue 2, Issue 3, Issue 4, Issue 5, Issue 6, Issue 7, Issue 8, Issue 9, Issue 10, Issue 11, Issue 12Volume 5:
Issue 1, Issue 2, Issue 3, Issue 4, Issue 5, Issue 6, Issue 7, Issue 8, Issue 9, Issue 10, Issue 11, Issue 12Volume 4:
Issue 1, Issue 2, Issue 3, Issue 4, Issue 5, Issue 6, Issue 7, Issue 8, Issue 9, Issue 10, Issue 11, Issue 12Volume 3:
Issue 1, Issue 2, Issue 3, Issue 4, Issue 5, Issue 6, Issue 7, Issue 8, Issue 9, Issue 10, Issue 11, Issue 12